STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
BNTC BENITEC BIOPHARMA INCORPORATED StockScouter® Report
8
StockScouter® Score
BENITEC BIOPHARMA INCORPORATED, a small cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- The multi-period measure of relative price change and consistency is well above average. Positive
- The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
Concerns
- One or more analysts has modestly decreased quarterly earnings estimates for BNTC. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
B
C
N/A
A